1. Home
  2. MPAA vs ALXO Comparison

MPAA vs ALXO Comparison

Compare MPAA & ALXO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Motorcar Parts  of America Inc.

MPAA

Motorcar Parts of America Inc.

HOLD

Current Price

$10.58

Market Cap

208.6M

ML Signal

HOLD

Logo ALX Oncology Holdings Inc.

ALXO

ALX Oncology Holdings Inc.

HOLD

Current Price

$1.53

Market Cap

240.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MPAA
ALXO
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
208.6M
240.8M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
MPAA
ALXO
Price
$10.58
$1.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
$17.50
$3.50
AVG Volume (30 Days)
36.2K
1.0M
Earning Date
06-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
60.56
26.36
EPS
0.13
N/A
Revenue
$757,354,000.00
N/A
Revenue This Year
$1.50
N/A
Revenue Next Year
$7.42
N/A
P/E Ratio
$82.08
N/A
Revenue Growth
5.53
N/A
52 Week Low
$9.29
$0.41
52 Week High
$18.12
$2.66

Technical Indicators

Market Signals
Indicator
MPAA
ALXO
Relative Strength Index (RSI) 41.71 29.50
Support Level $9.92 $1.37
Resistance Level $11.10 $1.59
Average True Range (ATR) 0.44 0.11
MACD -0.04 -0.05
Stochastic Oscillator 35.17 0.91

Price Performance

Historical Comparison
MPAA
ALXO

About MPAA Motorcar Parts of America Inc.

Motorcar Parts of America Inc is a supplier of automotive aftermarket non-discretionary replacement parts and test solutions and diagnostic equipment. It operate in the non-discretionary automotive aftermarket for replacement hard part in North America and includes products such as light-duty rotating electrical products, wheel hub products, brake-related products, and turbochargers. In addition, it sell test solutions and diagnostic equipment. The company operates in three segments Hard Parts, Test Solutions and Diagnostic Equipment, and Heavy Duty. Key revenue is generated from Hard Parts, which includes (i) light duty rotating electric products such as alternators and starters, (ii) wheel hub products, (iii) brake-related products, including brake calipers, brake boosters, brake rotors.

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

Share on Social Networks: